Testing a new vaccine for infants at 2, 4, and 6 months
Part of Brain & nervous system, Digestive system, Infections, Lungs & breathing clinical trials.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be 2 months old (between 50 and 70 days old) when they get the first vaccine.
- Your baby must have been born full-term (at least 37 weeks of pregnancy) and weighed at least 2.5 kg at birth.
- Your baby cannot have had any previous vaccines for diphtheria, tetanus, whooping cough, polio, or Hib.
- Your baby cannot have a fever (temperature 100.4°F or higher) within 3 days before getting the vaccine.
- Your baby cannot have taken certain strong medications or steroids (except for some creams or inhalers) within 30 days before the study starts.
- Your baby cannot have received other vaccines within 30 days before the first study vaccine or during the month after the third dose, except for routine vaccines like BCG, hepatitis B at birth, rotavirus, MMR, PCV, and flu shot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study tests an experimental vaccine (BK1803) to see if it is safe and effective in healthy infants aged 2 to 6 months. It may help protect against several serious diseases.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
Hear when a new Diphtheria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.